Daiichi Sankyo

ISIN JP3475350009

 | 

WKN A0F57T

Market cap (in EUR)
41,365.24 m
Country
Japan
Sector
Healthcare
Dividend yield
1.71%
 

Overview

Quote

GBP 19.24
30/04/2025 (gettex)
+0.86|+4.68%
daily change
52 weeks low/high
16.41
32.01

Description

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals Japan

Chart

30/04/2024 - 30/04/2025
Show more chart settings

Financials

Key metrics

Market capitalisation, EUR 41,365.24 m
EPS, EUR 0.95
P/B ratio 4.04
P/E ratio 22.53
Dividend yield 1.71%

Income statement (2024)

Revenue, EUR 11,539.67 m
Net income, EUR 1,809.37 m
Profit margin 15.68%

What ETF is Daiichi Sankyo in?

There are 264 ETFs which contain Daiichi Sankyo. All of these ETFs are listed in the table below. The ETF with the largest weighting of Daiichi Sankyo is the HSBC MSCI Japan Climate Paris Aligned UCITS ETF.

Performance

Returns overview

YTD -16.07%
1 month -1.34%
3 months -19.17%
6 months -26.07%
1 year -29.25%
3 years -6.89%
5 years -1.39%
Since inception (MAX) +516.78%
2024 +1.30%
2023 -19.60%
2022 +43.87%
2021 -26.10%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 35.50%
Volatility 3 years 39.47%
Volatility 5 years 37.38%
Return per risk 1 year -0.82
Return per risk 3 years -0.06
Return per risk 5 years -0.01
Maximum drawdown 1 year -48.73%
Maximum drawdown 3 years -48.73%
Maximum drawdown 5 years -53.17%
Maximum drawdown since inception -53.17%

Rolling 1 year volatility

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
  • Last 30 Days
  • Current Month
  • Last Month
  • YTD
  • 1 year
  • 3 years
  • 5 years
  • Custom Range